Vistin Pharma ASA: Invitation to Q3 2021 conference call
21 Octubre 2021 - 05:00AM
Vistin Pharma ASA: Invitation to Q3 2021 conference call
Oslo, Norway, 21 October 2021
Vistin Pharma ASA will release its third quarter 2021 results on
Thursday 28th of October 2021. Vistin Pharma will host a
conference call for all shareholders and interested parties
on Thursday 28th of October at 08:30 CET. There will be a
Q&A session following the management discussion.
The conference call will be held in English.
The third quarter conference call will be available via web and
audio through the following access points:
Telephone conference:Confirmation Code:
1860729International
dial-In: +44 (0)
2071 928338Norway, Oslo:
+47 21563015United States, New York: +1
6467413167
Webcast:
https://edge.media-server.com/mmc/p/u59e5tiq
*****
For further information, please contact:
Alexander KarlsenCFO+47 97053621alexander.karlsen@vistin.com
About Vistin Pharma | www.vistin.com
Vistin Pharma is a Norwegian pharmaceutical company producing
Metformin Hydrochloride (API). The Metformin is also available as
Direct Compressible lubricated granules. As a solely dedicated
European Metformin producer, Vistin Pharma is a well-positioned
supplier to leading pharmaceutical companies. Vistin Pharma is
headquartered in Oslo, Norway, and has highly qualified employees
and a dedicated manufacturing facility in Kragerø.
Vistin Pharma Asa (LSE:0RAM)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
Vistin Pharma Asa (LSE:0RAM)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024